Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by zxcvbnnmon Mar 13, 2018 1:17pm
47 Views
Post# 27707633

RE:RE:RE:RE:RE:Something Is Going To happen Here

RE:RE:RE:RE:RE:Something Is Going To happen HereI am not expecting too much. I am good if the company is liquidated or sold at net cash value so everyone gets out quickly unless the billing division really shows a sign of growth.

They don't need to announce if there are more small clients signed up. Only a mega contract would warrant a news release. 

Don't think he can just lend the money to PHM without shareholder approval as speficifed in the news press release and MD&A - any transaction will be subject to regulatory and shareholder approval. If he wants to take the company private, that's great. Whether the premium is sufficient enough again will be subject to shareholder approval. 
Bullboard Posts